Related Experiment Video
Updated: Jun 30, 2025
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.0K
[IN VITRO FERTILIZATION (IVF) TREATMENTS IN MACCABI HEALTHCARE SERVICES 2015-2020]
Noam Orvieto1, Yaakov Segal1, Shahar Kol1
1Maccabi Healthcare Services, Tel Aviv, Israel.
Harefuah
|March 20, 2024
Summary
In vitro fertilization (IVF) cycles increased from 2015-2020, driven by more frozen embryo transfer (FET) cycles. This trend, alongside rising patient age, may reflect updated Ministry of Health (MOH) recommendations for fertility treatments.
Area of Science:
- Reproductive Endocrinology
- In Vitro Fertilization (IVF) Outcomes
- Public Health Recommendations
Context:
- Previous summaries covered IVF outcomes from 2007-2014.
- In 2014, the Ministry of Health (MOH) recommended IVF for patients over 39 due to decreased ovarian reserve.
- This study examines trends following the 2014 MOH statement.
Purpose:
- To summarize IVF treatment outcomes between 2015 and 2020.
- To investigate changes in IVF treatment patterns post-MOH recommendation.
Summary:
- IVF cycles increased 2015-2020, primarily due to a rise in frozen embryo transfer (FET) cycles.
- The mean patient age increased to 37.5 years, with a notable rise in patients over 40.
- Private hospital utilization for IVF increased from 72% to 77% during the study period.
Impact:
- Findings suggest evolving patient demographics and treatment preferences in assisted reproductive technologies.
- The data may inform future public health policies regarding fertility treatments.
- Highlights the growing reliance on FET cycles in contemporary IVF practice.
Related Concept Videos
01:24In Vitro Fertilization
258
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
258
01:28Infertility in Females
292
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
292
01:23Infertility in Males
262
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
262
01:57Meiosis II
183.3K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
183.3K